Evaluation of the Japanese Respiratory Society guidelines for the identification of Mycoplasma pneumoniae pneumonia

Respirology

Volumn 17, Issue 7, 2012, Pages 1131-1136

  Yin, Yu Dong ^a   Zhao, Fei ^c,d   Ren, Li Li ^b   Song, Shu Fan ^a   Liu, Ying Mei ^c   Zhang, Jian Zhong ^c,d   Cao, Bin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d State Key Laboratory for Infectious Disease Prevention and Control   (China)

Author keywords

community acquired pneumonia; diagnosis; Japanese Respiratory Society guideline; Mycoplasma pneumoniae

Indexed keywords

ADENOVIRUS; ADULT; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; COMMUNITY ACQUIRED PNEUMONIA; DIFFERENTIAL DIAGNOSIS; ESCHERICHIA COLI; FEMALE; HUMAN; INFLUENZA VIRUS A; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; METAPNEUMOVIRUS; MYCOPLASMA PNEUMONIA; OUTPATIENT CARE; PARAINFLUENZA VIRUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHINOVIRUS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIA; VIRUS PNEUMONIA;

ADULT; COMMUNITY-ACQUIRED INFECTIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; JAPAN; MALE; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; PNEUMONIA, VIRAL; PRACTICE GUIDELINES AS TOPIC; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SOCIETIES, MEDICAL;

EID: 84866684751     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2012.02227.x     Document Type: Article

References (24)

1. Brar NK, Niederman MS,. Management of community-acquired pneumonia: a review and update. Ther. Adv. Respir. Dis. 2011; 5: 61-78.
2. Lauderdale TL, Chang FY, Ben RJ, et al,. Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan. Respir. Med. 2005; 99: 1079-86.
3. Lieberman D, Schlaeffer F, Boldur I, et al,. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax 1996; 51: 179-84.
4. Liu YN, Chen MJ, Zhao TM, et al,. A multicenter study on the pathogenic agents in 665 adult patients with community-acquired pneumonia in cities of China. Zhonghua Jie He He Hu Xi Za Zhi 2006; 29: 3-8.
5. Cao B, Ren LL, Zhao F, et al,. Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China. Eur. J. Clin. Microbiol. Infect. Dis. 2010; 29: 1443-8.
6. Liu FC, Chen PY, Huang FL, et al,. Do serological tests provide adequate rapid diagnosis of Mycoplasma pneumoniae infection ? Jpn J. Infect. Dis. 2008; 61: 397-9.
7. Uldum SA, Jensen JS, Sondergard-Andersen J, et al,. Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae. J. Clin. Microbiol. 1992; 30: 1198-204.
8. Porath A, Schlaeffer F, Lieberman D,. The epidemiology of community-acquired pneumonia among hospitalized adults. J. Infect. 1997; 34: 41-8.
9. Cunha BA,. The atypical pneumonias: clinical diagnosis and importance. Clin. Microbiol. Infect. 2006; 12 (Suppl. 3): 12-24.
10. Yanagihara K, Kohno S, Matsusima T,. Japanese guidelines for the management of community-acquired pneumonia. Int. J. Antimicrob. Agents 2001; 18 (Suppl. 1): S45-8.
11. Ishida T, Miyashita N, Nakahama C,. Clinical differentiation of atypical pneumonia using Japanese guidelines. Respirology 2007; 12 (1): 104-10.
12. Miyashita N, Fukano H, Yoshida K, et al,. Is it possible to distinguish between atypical pneumonia and bacterial pneumonia? Evaluation of the guidelines for community-acquired pneumonia in Japan. Respir. Med. 2004; 98: 952-60.
13. Ieven M, Ursi D, Van Bever H, et al,. Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients. J. Infect. Dis. 1996; 173: 1445-52.
14. Li X, Atkinson TP, Hagood J, et al,. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Pediatr. Infect. Dis. J. 2009; 28: 693-6.
15. Dumke R, Schurwanz N, Lenz M, et al,. Sensitive detection of Mycoplasma pneumoniae in human respiratory tract samples by optimized real-time PCR approach. J. Clin. Microbiol. 2007; 45: 2726-30.
16. Coiras MT, Perez-Brena P, Garcia ML, et al,. Simultaneous detection of influenza A, B, and C viruses, respiratory syncytial virus, and adenoviruses in clinical samples by multiplex reverse transcription nested-PCR assay. J. Med. Virol. 2003; 69: 132-44.
17. Coiras MT, Aguilar JC, Garcia ML, et al,. Simultaneous detection of fourteen respiratory viruses in clinical specimens by two multiplex reverse transcription nested-PCR assays. J. Med. Virol. 2004; 72: 484-95.
18. Dorigo-Zetsma JW, Zaat SA, Wertheim-van Dillen PM, et al,. Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children. J. Clin. Microbiol. 1999; 37: 14-7.
19. Jacobs E,. Serological diagnosis of Mycoplasma pneumoniae infections: a critical review of current procedures. Clin. Infect. Dis. 1993; 17 (Suppl. 1): S79-82.
20. Zigangirova NA, Popova OV, Solovjeva CV, et al,. Development of a PCR-based method for diagnosing Mycoplasma pneumoniae infections. Lett. Appl. Microbiol. 1993; 16: 106-9.
21. Cunha BA,. Clinical features of Legionnaires disease. Semin. Respir. Infect. 1998; 13: 116-27.
22. Olaechea PM, Quintana JM, Gallardo MS, et al,. A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission. Intensive Care Med. 1996; 22: 1294-300.
23. Ishida T, Hashimoto T, Arita M, et al,. Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest 1998; 114: 1588-93.
24. Jover F, Cuadrado JM, Andreu L, et al,. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia. Eur. J. Intern. Med. 2008; 19: 15-21.